164 related articles for article (PubMed ID: 6104798)
1. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
[TBL] [Abstract][Full Text] [Related]
2. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
[TBL] [Abstract][Full Text] [Related]
3. Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism.
Arató M; Bagdy G; Perényi A; Béla A
Psychiatry Res; 1984 Apr; 11(4):347-51. PubMed ID: 6146151
[TBL] [Abstract][Full Text] [Related]
4. Serum prolactin and tardive dyskinesia.
Glazer WM; Moore DC; Bowers MD; Brown WA
Am J Psychiatry; 1981 Nov; 138(11):1493-6. PubMed ID: 6117204
[TBL] [Abstract][Full Text] [Related]
5. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
6. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
Csernansky JG; Kaplan J; Holman CA; Hollister LE
Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
[TBL] [Abstract][Full Text] [Related]
7. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
[TBL] [Abstract][Full Text] [Related]
8. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K
Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210
[TBL] [Abstract][Full Text] [Related]
10. High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia.
Lerner V; Miodownik C; Kaptsan A; Vishne T; Sela BA; Levine J
J Clin Psychiatry; 2005 Dec; 66(12):1558-63. PubMed ID: 16401157
[TBL] [Abstract][Full Text] [Related]
11. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
Tripodianakis J; Markianos M; Garelis E
Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
[TBL] [Abstract][Full Text] [Related]
13. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
Chouinard G
J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
[TBL] [Abstract][Full Text] [Related]
15. Normal prolactin responses in tardive dyskinesia.
Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
[TBL] [Abstract][Full Text] [Related]
16. Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
Souza RP; Meltzer HY; Lieberman JA; Voineskos AN; Remington G; Kennedy JL
Hum Psychopharmacol; 2011 Jan; 26(1):21-7. PubMed ID: 21305610
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.
Albus M; Naber D; Müller-Spahn F; Douillet P; Reinertshofer T; Ackenheil M
Biol Psychiatry; 1985 Oct; 20(10):1082-9. PubMed ID: 2864087
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism.
Burnett GB; Prange AJ; Wilson IC; Jolliff LA; Creese IC; Synder SH
Neuropsychobiology; 1980; 6(2):109-20. PubMed ID: 6101910
[TBL] [Abstract][Full Text] [Related]
20. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
